KYMR vs PPL · rev $99.4M vs P/E 22, rev $9.04B
Kymera Therapeutics Inc (KYMR) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
Latest reported PPL revenue for 2025-12-31 was $9.04B. Net income was $1.18B. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
KYMR currently screens at market cap $7.39B. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the KYMR and PPL stock pages for the full models.
Not investment advice.